메뉴 건너뛰기
Clinical Therapeutics
Volumn 29, Issue SUPPL. A, 2007, Pages
Progression of fabry cardiomyopathy
Author keywords

[No Author keywords available]
Indexed keywords

ARTICLE; CARDIOMYOPATHY; DISEASE COURSE; DISEASE SEVERITY; ELECTROCARDIOGRAM; ENZYME REPLACEMENT; FABRY DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HUMAN; HYPERTENSION; NONHUMAN;
EID: 34250222998     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(07)80120-2     Document Type: Article
Times cited : (6)
References (7)
  • 1
    • 34250190677 scopus 로고    scopus 로고
    • Cardiac involvement in Fabry disease. About numbers and notions
    • Strotmann J.M., Pinderski L., Bultas J., et al. Cardiac involvement in Fabry disease. About numbers and notions. Eur Heart J 27 (2006) 293
    • (2006) Eur Heart J , vol.27 , pp. 293
    • Strotmann, J.M.1    Pinderski, L.2    Bultas, J.3
  • 2
    • 0343618421 scopus 로고    scopus 로고
    • New insights in cardiac structural changes inpatients with Fabry's disease
    • Linhart A., Palecek T., Bultas J., et al. New insights in cardiac structural changes inpatients with Fabry's disease. Am Heart J 139 (2000) 1101-1108
    • (2000) Am Heart J , vol.139 , pp. 1101-1108
    • Linhart, A.1    Palecek, T.2    Bultas, J.3
  • 3
    • 0037461097 scopus 로고    scopus 로고
    • Early detection of Fabry card iomyopathy by tissue Doppler imaging
    • Pieroni M., Chimenti C., Ricci R., et al. Early detection of Fabry card iomyopathy by tissue Doppler imaging. Circulation 107 (2003) 1978-1984
    • (2003) Circulation , vol.107 , pp. 1978-1984
    • Pieroni, M.1    Chimenti, C.2    Ricci, R.3
  • 4
    • 0141765881 scopus 로고    scopus 로고
    • Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: A prospective strain rate imaging study
    • Weidemann F., Breunig F., Beer M., et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: A prospective strain rate imaging study. Circulation 108 (2003) 1299-1301
    • (2003) Circulation , vol.108 , pp. 1299-1301
    • Weidemann, F.1    Breunig, F.2    Beer, M.3
  • 5
    • 20844452038 scopus 로고    scopus 로고
    • The variation of morphological and functional cardiac manifestation in Fabry disease: Potential implications for the time course of the disease
    • Weidemann F., Breunig F., Beer M., et al. The variation of morphological and functional cardiac manifestation in Fabry disease: Potential implications for the time course of the disease. Eur Heart J 26 (2005) 1221-1227
    • (2005) Eur Heart J , vol.26 , pp. 1221-1227
    • Weidemann, F.1    Breunig, F.2    Beer, M.3
  • 6
    • 33646680506 scopus 로고    scopus 로고
    • Cardiac and vascular hypertrophy in Fabry disease: Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition
    • Barbey F., Brakch N., Linhart A., et al. Cardiac and vascular hypertrophy in Fabry disease: Evidence for a new mechanism independent of blood pressure and glycosphingolipid deposition. Arterioscler Thromb Vasc Biol 26 (2006) 839-844
    • (2006) Arterioscler Thromb Vasc Biol , vol.26 , pp. 839-844
    • Barbey, F.1    Brakch, N.2    Linhart, A.3
  • 7
    • 34250192981 scopus 로고    scopus 로고
    • Weidmann F, Niemann M, Breunig F. Regression of left ventricular hypertrophy in patients with Fabry cardiomyopathy during long term enzyme replacement therapy. The impact of the baseline conditions. Eur J Echocardiogr. In press

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.